Araloside A

Triterpenoids

NP7024

7518-22-1

Araloside A

The use of Chikusetsusaponin IV, Chikusetsusaponin IVa, chikusetsusaponin V, polysciasaponin P5, or a crude extract of P. japonicus containing these saponins is expected to relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.

Chikusetsusaponin IV; 28-(β-D-Glucopyranosyloxy)-28-oxoolean-12-en-3β-yl 4-O-α-L-arabinofuranosyl-β-D-glucopyranosiduronic acid

C47H74O18

>98%

Powder

Powder